Turnstone Biologics Corp. Common Stock (TSBX) — Net Asset Momentum
Turnstone Biologics Corp. Common Stock (TSBX) recorded a net asset momentum of -68.1% as of December 2024, with net assets of $31.47 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. For live market cap and overall valuation, see Turnstone Biologics Corp. Common Stock market capitalisation.
YoY Momentum
Current Net Assets
Years of Data
Country
Turnstone Biologics Corp. Common Stock Net Asset Momentum (2021–2024)
This chart tracks Turnstone Biologics Corp. Common Stock's year-over-year net asset growth across 4 annual reporting periods from 2021 to 2024. The most recent momentum reading is -68.1%, with net assets of $31.47 Million USD as of December 2024. See net asset quality index of Turnstone Biologics Corp. Common Stock to measure how much of total assets are equity-financed.
Annual Net Asset History for Turnstone Biologics Corp. Common Stock (2021–2024)
The table below shows the complete annual net asset history for Turnstone Biologics Corp. Common Stock from 2021 to 2024, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check TSBX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $31.47 Million | $40.14 Million | $8.67 Million | ▼ -68.1% |
| 2023 | $98.67 Million | $112.81 Million | $14.15 Million | ▲ +197.2% |
| 2022 | $-101.47 Million | $114.94 Million | $216.41 Million | ▼ -24.0% |
| 2021 | $-81.85 Million | $187.24 Million | $269.10 Million | — |